Business Segments · Other
Oncology & Multispecialty — Other
Year-over-year, this metric grew by 100.0%, from -$250.00K to $0.00. This is a positive signal — lower values indicate better performance for this metric.
Analysis
StatementSegment
CategoryOther
SignalLower is better
VolatilityStable
First reportedQ1 2025
Last reportedQ4 2026May 8, 2026
Rolls up toForeign exchange and other
How to read this metric
Large, unexplained values in this category may warrant further investigation into segment transparency.
Detailed definition
Residual items within the oncology and multispecialty segment that do not fit into defined categories like revenue, depr...
Peer comparison
Commonly used in segment reporting to balance the total segment profit/loss.
Metric ID:
mck_segment_oncology_multispecialty_otherHistorical Data
2 years
| FY'25 | FY'26 | |
|---|---|---|
| Value | -$1.00M | $0.00 |
| YoY Change | — | +100.0% |
Range-$1.00M – $0.00
Avg YoY Growth+100.0%
Median YoY Growth+100.0%
Similar Metrics at Other Companies
Frequently Asked Questions
- What is McKesson's oncology & multispecialty — other?
- McKesson (MCK) reported oncology & multispecialty — other of $0.00 in Q1 2026.
- How has McKesson's oncology & multispecialty — other changed year-over-year?
- McKesson's oncology & multispecialty — other increased by 100.0% year-over-year, from -$250.00K to $0.00.
- What does oncology & multispecialty — other mean?
- Miscellaneous segment expenses or income not otherwise categorized.